Effect of Antioxidant Probiotic Administration on Seminal Quality and Reproductive Outcomes.
Sponsor: ADM Protexin
A NA clinical study on Male Infertility, this trial is completed. The trial is conducted by ADM Protexin and has accumulated 11 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2025 — Sep 2025 [monthly]
Recruiting NA
-
Sep 2024 — Mar 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 6 earlier versions
-
Sep 2022 — Apr 2024 [monthly]
Recruiting NA
-
Apr 2022 — Sep 2022 [monthly]
Recruiting NA
-
Apr 2021 — Apr 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ADM Protexin
- Biopolis S.L.
- Fundación IVI
- Instituto Valenciano de Infertilidad, IVI VALENCIA
For direct contact, visit the study record on ClinicalTrials.gov .